DIA 2015 Annual Meeting Recap

In Clinical6 by Brandy ReedLeave a Comment

Last week, the Parallel 6 team spent an event packed week in Washington D.C. for the 51st annual DIA meeting. The theme of the event, Develop. Innovate. Advance, reminded us that we are so fortunate to be surrounded by other influencers in the life sciences industry that strive to advance medicine around the world. We’ve picked out several of the highlights from the event that continue to inspire us to develop, innovate and advance.

1. Keynote Speaker Dan Burrus

During Burrus’ speech he emphasized the importance of collaboration. Rather than cooperate, we should collaborate and make progressive steps together to advance life sciences. At Parallel 6, we’ve partnered with MMG to solve the hurdles of clinical trial recruitment. We combine our digital recruitment tools with their expertise in clinical trial recruitment to reach more patient candidates and enroll them into clinical trials.

2. Big Data

A large topic of discussion during the annual meeting was around big data and it’s a topic that we’re eager to discuss. Capturing big data for clinical trials is going to have a major impact on the industry by providing faster insights into adverse events and trial outcomes. Many CROs are already integrating a clinical trial management system into their mobile strategy that allows data to be captured across multiple clinical trials in real time.

3. Clinical Trial Transparency

The ongoing trend in life sciences is being patient centric which means fostering open communication and transparency between the patients and the CROs. We’re excited to see eConsent take off, as a result, and increase transparency while recruiting patients and retaining patients throughout a clinical trial.

4. Social Media Strategies

There were over a dozen social media educational programs available at this year’s event. It goes to show that the traditional methods of recruiting patients is fading away. Social media is making it easier to target patient candidates, participate in their conversations and direct them to a clinical trial that they qualify for. It’s not only helping to reduce gender bias, but it’s enabling CROs to recruit patients across a large geographic area.

What were your favorite moments from DIA 2015? Contact us today to learn more about Clinical 6 and its contribution to develop, innovate and advance the life sciences industry. 

Leave a Comment